Abstract
Paclitaxel is an antineoplastic agent that is used in the treatment of a variety of solid tumors. Dose-limiting side effects of myelosuppression and peripheral neuropathy are well known. Paclitaxel has minimal penetration of the blood-brain barrier and central nervous system side effects are rare. However, transient encephalopathy following paclitaxel infusion has been described in adults but not in children. We present the case of a 14-year-old female with a recurrent suprasellar germinoma who developed an acute encephalopathy 4-6 hr following paclitaxel infusion.
Original language | English (US) |
---|---|
Pages (from-to) | 699-700 |
Number of pages | 2 |
Journal | Pediatric Blood and Cancer |
Volume | 50 |
Issue number | 3 |
DOIs | |
State | Published - Mar 2008 |
Keywords
- Brain tumor
- Encephalopathy
- Neurotoxicity
- Paclitaxel
- Transient
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Hematology
- Oncology